Posted by saturn on February 24, 2007, at 10:19:52
http://news.yahoo.com/s/ap/20070223/ap_on_he_me/adhd_drug
So the FDA is recommending this new form of amphetamine be schedule II. Interesting.
I wonder if Shire expected this? I believe they almost deserve it.
I mean strictly from a profit aspect it seems their R&D resources could have been much better placed. I'd think there would be a much larger market for people with ADHD who can't tolerate amphetamine or other currently available treatments, than those who can tolerate amphetamine and are at high risk for abusing it.
BTW, does anyone know if this new formulation is racemic or just altered d-amphetamine?
Later...Saturn.
poster:saturn
thread:735699
URL: http://www.dr-bob.org/babble/20070224/msgs/735699.html